Handa Pharmaceuticals, Inc. (TPEX: 6620)
Health Care · Pharmaceuticals · TW
NT$127.50
-11.15% today · -15.3% 1Y
Handa Pharmaceuticals, Inc. (TPEX: 6620) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $648.08M and employs 15 people.
Over the last twelve months the share price has lost 15.3%, trading between 64.10 and 155.00.
Tweenvest scores Handa Pharmaceuticals, Inc. across four factors: quality 98/100, value 25/100, dividend 39/100. Its strongest factor is quality.
6620 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $648.08M
- Revenue (TTM)
- $38.06M
- P/E
- 42.24
- EPS
- 3.02
- Dividend yield
- 1.57%
- Beta (5Y)
- 0.67
- 52-week high
- NT$155.00
- 52-week low
- NT$64.10
- Avg volume (3M)
- —
- Shares outstanding
- 162.53M
- Employees
- 15
- Next earnings
- —
About Handa Pharmaceuticals, Inc.
Handa Pharmaceuticals, Inc. operates as a specialized drug company, concentrating its efforts on creating and advancing new medications for diverse health issues across both the United States and China. The firm currently offers Quetiapine XR, a treatment for Schizophrenia, as well as Dexlansoprazole DR capsules. Beyond its existing portfolio, Handa is actively cultivating a robust pipeline of therapies. This includes their cutting-edge ONCORE drug delivery platform, engineered to boost patient adherence and improve the safety of tyrosine kinase inhibitor oncology drugs. Other significant projects encompass a 505(b)(2)NDA therapeutic agent, Tascenso ODT for managing multiple sclerosis, and the oncology candidates HND-033 and HND-027. Furthermore, the company's development initiatives feature HND-004, designed for diabetic patients; HND-032, intended to aid in smoking cessation; and HND-026, a gastrointestinal medication. Founded in 2014, Handa Pharmaceuticals, Inc. has its main corporate headquarters situated in Tainan City, Taiwan.
- ISIN
- TW0006620008
- Founded
- 2014
- Listed since
- Dec 30, 2016
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PT Tempo Scan Pacific TbkIDX: TSPC | $662.85M | Rp2,630.00 | -0.38% |
| Tianjin Lisheng Pharmaceutical Co.,Ltd.SZSE: 002393 | $655.52M | CN¥14.25 | +1.21% |
| Zhejiang Sunflower Great Health Co., Ltd.SZSE: 300111 | $655.32M | CN¥3.41 | +14.43% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.SHSE: 600613 | $648.15M | CN¥8.72 | +6.47% |
| Chong Kun Dang Pharmaceutical Corp.KOSE: A185750 | $645.88M | ₩65,900.00 | +1.07% |
| LanZhou Foci Pharmaceutical Co.,Ltd.SZSE: 002644 | $639.65M | CN¥8.39 | +1.57% |
| Chimin Health Management Co., Ltd.SHSE: 603222 | $636.24M | CN¥8.30 | +2.85% |
| Zhejiang Wecome Pharmaceutical Company LimitedSZSE: 300878 | $634.11M | CN¥29.90 | -0.86% |
Figures last refreshed Oct 11, 2026.